Clinical Trial Update: Assessment of the Phototoxic Potential of LEO 29102 Cream [Phase 1]

View source ↗

Summary

Phase 1 trial assessing phototoxic potential of LEO 29102 Cream in atopic dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atopic Dermatitis

Drugs mentioned

• LEO 29102 Cream

Snippet

Sponsor: LEO Pharma | Conditions: Atopic Dermatitis | Phase 1 | Status: COMPLETED